カテゴリ： Grand View Research, 世界, 医療/バイオ

神経血栓除去装置のグローバル市場2023-2030：血栓レトリーバー、血管スネア

■ 英語タイトル：Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Vascular Snares), By End-use (Hospitals, ASCs), By Region (Asia Pacific, North America), And Segment Forecasts, 2023 - 2030

調査会社Grand View Research社が発行したリサーチレポート（データ管理コード：GRV23AUG047）■ 発行会社/調査会社：Grand View Research
■ 商品コード：GRV23AUG047
■ 発行日：2023年7月25日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[神経血栓除去装置のグローバル市場2023-2030：血栓レトリーバー、血管スネア]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

神経血栓除去装置市場の成長と動向
Grand View Research, Inc.の最新レポートによると、神経血栓摘出装置の世界市場規模は、2023年から2030年にかけてCAGR 6.8%で成長し、2030年には11億ドルに達する見込みです。市場成長の原動力となっているのは、脳卒中の有病率の増加、不健康なライフスタイルの採用率の上昇、低侵襲手術に対する需要の増加、市場参入企業による様々な戦略的イニシアチブの採用など、様々な要因です。従来の開頭手術と比較して、これらのデバイスは、頭蓋内腔への容易なアクセス、最小限の侵襲、神経血栓摘出デバイスに関連する高度な設計や機能による困難な手順の簡素化など、創傷閉鎖を簡素化し、より迅速な治癒を可能にする利点を提供します。

さらに、あらゆる年齢層でより審美的で自然な外観への関心が高まっていることや、低侵襲手術中の出血量が少ないことが、市場成長の主な推進要因の1つとなっています。このような処置は、侵襲的処置よりもさらに外傷を減らし、迅速な回復を促進するのに役立つと期待されています。このように、神経血栓除去装置は出血量が少なく、回復が早いため、低侵襲手術の需要が高まると予想されています。さらに、技術的に高度な製品の導入と迅速な製品承認プロセスは、予測期間中の市場成長を促進すると予想される要因です。AISおよびその関連症状の治療用神経血栓除去装置の開発には、他にもさまざまな技術が用いられています。例えば、2023年6月、Penumbra社はlightning Bolt7動脈血栓除去システムを発表しました。この装置は、血栓と血流の違いを識別するのに役立ちます。

神経血栓除去装置市場レポートハイライト

- 製品別では、急性虚血性脳卒中の有病率の上昇と主要市場参入企業による製品発売の増加により、血栓回収装置が58.24%のシェアで2022年の市場を独占しました。

- 最終用途別では、医療施設の改善と病院での高度な機器の利用可能性により、病院分野が2022年に71.14%のシェアで市場を支配しました。

- 欧州は、急性虚血性脳卒中の患者数が増加していることから、2022年の売上シェアは32.55%で最大となり、市場をリードしました。

第1章. 調査手法＆範囲
第2章. エグゼクティブサマリー
第3章. 神経血栓除去装置の市場変動・動向・範囲
第4章. 神経血栓除去装置市場：製品別予測＆動向分析
第5章. 神経血栓除去装置市場：最終用途別予測＆動向分析
第6章. 神経血栓除去装置市場：地域別予測＆動向分析
第7章. 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of acute ischemic strokes
3.4.1.2. Introduction of technologically advanced products
3.4.1.3. Rising Adoption of unhealthy lifestyle
3.4.2. Market restraint analysis
3.4.2.1. Stringent and complex regulatory framework
3.4.2.2. Risks associated with the neurothrombectomy devices
3.5. Neurothrombectomy Devices Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. The threat of new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Clot Retrievers
4.1.2. Aspiration/Suction Devices
4.1.3. Vascular Snares
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Neurothrombectomy Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clot Retrievers
4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Aspiration/Suction Devices
4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.3 Vascular Snares
4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospital
5.1.2. Emergency Clinics
5.1.3. Ambulatory Surgical Centers
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Neurothrombectomy Devices Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospital
5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Emergency Clinics
5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Ambulatory Surgical Centers
5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 – 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 – 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 – 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 – 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 – 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 – 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 – 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 – 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 – 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 – 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 – 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 – 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Acandis GmbH
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Phenox GmbH
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Stryker
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Penumbra, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Vesalio
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America neurothrombectomy devices market, by Region, 2018 - 2030 (USD Million)
Table 3 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 4 North America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 8 Canada neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 10 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 11 Europe neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 13 UK neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 15 Germany neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 17 France neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 19 Italy neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 21 Spain neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 24 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 26 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 27 Norway neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 32 Japan neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 33 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 34 China neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 35 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 36 India neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 38 Australia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 46 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 55 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 60 UAE neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 神経血栓除去装置のグローバル市場（～2030年）：血栓回収装置、吸引/吸引装置、血管スネア
  • 神経血栓除去装置のグローバル市場2024-2030：血栓回収装置、吸引装置
  • ウェアラブルインジェクターのグローバル市場2024-2030：オンボディ、オフボディ
  • 再生医療用画像機器のグローバル市場（2024～2030）：X線、超音波、コンピュータ断層撮影、磁気共鳴画像法、核医画像機器
  • 神経血管塞栓装置の世界市場2023-2030：市場規模、シェア、動向分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GRV23AUG047 )"神経血栓除去装置のグローバル市場2023-2030：血栓レトリーバー、血管スネア" (英文：Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Vascular Snares), By End-use (Hospitals, ASCs), By Region (Asia Pacific, North America), And Segment Forecasts, 2023 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。